Overview of integrated screening framework (IMAGE)
Caption
In an integrated approach for drug discovery, natural product fractions are isolated from marine bacteria, screened through two biological screening platforms, and subjected to high-resolution mass spectrometry-based metabolomics profiling. Data are integrated using Similarity Network Fusion, which then provides biological annotation on individual metabolites identified.
Credit
Hight et al., PNAS 2022
Usage Restrictions
For use only with news coverage of this research
License
Original content